C4 Therapeutics
CCCC
CCCC
114 hedge funds and large institutions have $353M invested in C4 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
1% more funds holding
Funds holding: 113 → 114 (+1)
Holders
114
Holding in Top 10
–
Calls
$257K
Puts
$36K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.2M | |
| 3 | +$6.91M | |
| 4 |
Goldman Sachs
New York
|
+$2.54M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.35M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$6.58M | |
| 3 | -$5.32M | |
| 4 |
Millennium Management
New York
|
-$3.21M |
| 5 |
RI
RTW Investments
New York
|
-$2.41M |